Michelle Brennan
Director/Board Member at CARDINAL HEALTH, INC.
Net worth: 591 839 $ as of 30/03/2024
Profile
Michelle Brennan is an Independent Director at Cardinal Health, Inc., Director at Masimo Corp., and Director at Perosphere Technologies, Inc. She is also an Advisor at Tau Ventures LLC.
Previously, she was the Group Chairman-EMEA Medical Devices at Johnson & Johnson Foundation Scotland from 2015 to 2018.
She was also the Chairman at MedTech Europe.
Additionally, she served as an Independent Director at Coupa Software, Inc. from 2020 to 2023 and was a Member of the Life Sciences Council from 2018 to 2020.
Ms. Brennan received her undergraduate degree from the University of Kansas in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CARDINAL HEALTH, INC.
0.00% | 14/11/2023 | 5,289 ( 0.00% ) | 591 839 $ | 30/03/2024 |
Michelle Brennan active positions
| Companies | Position | Start |
|---|---|---|
| CARDINAL HEALTH, INC. | Director/Board Member | 05/09/2022 |
| MASIMO CORPORATION | Director/Board Member | 25/06/2023 |
Tau Ventures LLC
 Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Consultant / Advisor | - |
Perosphere Technologies, Inc.
 Perosphere Technologies, Inc. Packaged SoftwareTechnology Services Perosphere Technologies, Inc. is a private medical technologies company that is focused on developing and commercializing the novel POC (point-of-care) coagulometer. The company is based in Danbury, CT. This diagnostic tool informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. The POC coagulometer is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including direct oral anticoagulants (DOACs). The fast diagnosis and related appropriate treatment decisions the POC coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The CEO of the company is Sasha H. Bakhru. | Director/Board Member | 01/08/2023 |
Former positions of Michelle Brennan
| Companies | Position | End |
|---|---|---|
| COUPA SOFTWARE INCORPORATED | Director/Board Member | 27/02/2023 |
| Life Sciences Council | Corporate Officer/Principal | 31/12/2019 |
Johnson & Johnson Foundation Scotland
 Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Director/Board Member | - |
| MedTech Europe | Chairman | - |
Training of Michelle Brennan
| University of Kansas | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| MASIMO CORPORATION | Health Technology |
| Private companies | 6 |
|---|---|
Coupa Software, Inc.
 Coupa Software, Inc. Packaged SoftwareTechnology Services Part of Thoma Bravo LP, Coupa Software, Inc. is a private company that develops an AI platform for procurement, payment, finance, and supply chain management. The company is based in San Mateo, CA. The company was founded in 2006 by David Robert Stephens and Noah Eisner. Leagh E. Turner has been the CEO of the company since 2023. Coupa Software was acquired by Thoma Bravo LP. | Technology Services |
Johnson & Johnson Foundation Scotland
Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Commercial Services |
| MedTech Europe | |
Perosphere Technologies, Inc.
Perosphere Technologies, Inc. Packaged SoftwareTechnology Services Perosphere Technologies, Inc. is a private medical technologies company that is focused on developing and commercializing the novel POC (point-of-care) coagulometer. The company is based in Danbury, CT. This diagnostic tool informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. The POC coagulometer is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including direct oral anticoagulants (DOACs). The fast diagnosis and related appropriate treatment decisions the POC coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The CEO of the company is Sasha H. Bakhru. | Technology Services |
Tau Ventures LLC
Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Finance |
| Life Sciences Council |
- Stock Market
- Insiders
- Michelle Brennan
